Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study
Autor: | Jamie J Kirkham, Ellen Copson, Baek Kim, Shelley Potter, Charlotte E. Coles, Nisha Sharma, Elizabeth Camacho, Kieran Horgan, Stuart McIntosh, Daniel R. Leff, Rachel O'Connell, Rajiv V. Dave, Chris Holcombe, Ramsey I. Cutress, Patricia Fairbrother, Christopher W. J. Cartlidge, Ashu Gandhi, Vicky P. Taxiarchi, Alona Courtney, Tim Rattay, Raghavan Vidya, Cliona C. Kirwan |
---|---|
Přispěvatelé: | Dave, Rajiv V. [0000-0001-6827-8090], McIntosh, Stuart A. [0000-0002-4123-9611], Potter, Shelley [0000-0002-6977-312X], Copson, Ellen [0000-0001-8994-4056], Apollo - University of Cambridge Repository, Cancer Research UK, Dave, Rajiv V [0000-0001-6827-8090], McIntosh, Stuart A [0000-0002-4123-9611] |
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Cancer Research
692/700/784 medicine.medical_treatment Cohort Studies 0302 clinical medicine Breast cancer Quality of life Surgical oncology Pandemic Epidemiology 030212 general & internal medicine 692/700/1538 Aged 80 and over Covid19 health policy Middle Aged Health care economics Health policy Oncology 030220 oncology & carcinogenesis Practice Guidelines as Topic Female Breast reconstruction Life Sciences & Biomedicine B-MaP-C study collaborative Cohort study Adult medicine.medical_specialty Breast Neoplasms Article 1117 Public Health and Health Services 692/4028/546 surgical oncology 03 medical and health sciences breast cancer SDG 3 - Good Health and Well-being medicine Humans 1112 Oncology and Carcinogenesis 692/700/3934 Oncology & Carcinogenesis Aged Science & Technology business.industry SARS-CoV-2 COVID-19 health care economics medicine.disease Radiation therapy quality of life Emergency medicine 692/4028/67/1347 business |
Zdroj: | British Journal of Cancer Dave, R V, Kim, B, Courtney, A, O'Connell, R L, Rattay, T, Taxiarchi, V, Kirkham, J J, Camacho, E, Fairbrother, P, Sharma, N, Cartlidge, C W J, Horgan, K, McIntosh, S A, Leff, D R, Vidya, R, Potter, S, Holcombe, C, Copson, E, Coles, C, Cutress, R I, Gandhi, A & Kirwan, C 2021, ' Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study ', British Journal of Cancer . https://doi.org/10.1038/s41416-020-01234-4 Dave, R V, Potter, S, Kirwan, C C, Fairhurst, K J, al., E 2021, ' Breast Cancer Management Pathways during the COVID-19 pandemic : Outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study ', British Journal of Cancer, vol. 124, no. 11, pp. 1785-1794 . https://doi.org/10.1038/s41416-020-01234-4 |
ISSN: | 1532-1827 0007-0920 |
Popis: | Background The B-MaP-C study aimed to determine alterations to breast cancer (BC) management during the peak transmission period of the UK COVID-19 pandemic and the potential impact of these treatment decisions. Methods This was a national cohort study of patients with early BC undergoing multidisciplinary team (MDT)-guided treatment recommendations during the pandemic, designated ‘standard’ or ‘COVID-altered’, in the preoperative, operative and post-operative setting. Findings Of 3776 patients (from 64 UK units) in the study, 2246 (59%) had ‘COVID-altered’ management. ‘Bridging’ endocrine therapy was used (n = 951) where theatre capacity was reduced. There was increasing access to COVID-19 low-risk theatres during the study period (59%). In line with national guidance, immediate breast reconstruction was avoided (n = 299). Where adjuvant chemotherapy was omitted (n = 81), the median benefit was only 3% (IQR 2–9%) using ‘NHS Predict’. There was the rapid adoption of new evidence-based hypofractionated radiotherapy (n = 781, from 46 units). Only 14 patients (1%) tested positive for SARS-CoV-2 during their treatment journey. Conclusions The majority of ‘COVID-altered’ management decisions were largely in line with pre-COVID evidence-based guidelines, implying that breast cancer survival outcomes are unlikely to be negatively impacted by the pandemic. However, in this study, the potential impact of delays to BC presentation or diagnosis remains unknown. |
Databáze: | OpenAIRE |
Externí odkaz: |